|
answer text |
<p>Since 1 April 2013 NHS England has been responsible for commissioning Alternative
and Augmentative Communication (AAC) aids for patients with complex disability whose
needs require specialised assessment, including for patients with motor neurone disease.
Commissioning of non-specialised AAC aids is the responsibility of local clinical
commissioning groups.</p><p> </p><p> </p><p> </p><p>NHS England has identified an
additional £22.5 million funding for AAC and Environmental Controls in 2014-15. A
process to identify appropriate providers, and ensure they were able to meet the AAC
service specification and standards began in April this year as soon as the budget
was confirmed. The specification can be found at:</p><p> </p><p> </p><p> </p><p><a
href="http://www.england.nhs.uk/wp-content/uploads/2013/06/d01-com-dis-equ-alt-aug-comm-aids.pdf"
target="_blank">www.england.nhs.uk/wp-content/uploads/2013/06/d01-com-dis-equ-alt-aug-comm-aids.pdf</a></p><p>
</p><p> </p><p> </p><p>The identification of providers was completed in August, and
just under £15 million specifically for AAC was transferred to Local Area Team commissioners
to agree contracts. During this process, NHS England worked closely with the Motor
Neurone Disease Association to ensure that funding was equitably distributed in a
fair and consistent manner. The 13 AAC providers selected are in the process of recruiting
the required additional specialist therapy staff. Services are already accepting referrals
and patients are being prioritised according to their clinical need, with priority
being given to patients with life limiting conditions.</p><p> </p>
|
|